ExaCare AI
PrivateLast Round
Series A
Oct 16, 2025
Total Funding Raised
$36.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ExaCare AI operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in October 2025.
ExaCare AI is a healthcare technology company that provides an AI-powered platform to automate and streamline patient admissions for post-acute care facilities.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Workflow Automation, Vertical SaaS, Healthcare Analytics, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExaCare AI Comparables
Compare ExaCare AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Freed | 88% | |
| Magicare AI | 81% | |
| Nabla | 79% |
For institutional investors. Book with your work email.
ExaCare AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 16, 2025 | ||||
| Seed | Dec 30, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ExaCare AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bienville Capital | Series A, Seed |
| Foundation Capital | Series A |
| Foundation Capital | Series A, Seed |
| Bienville Capital | Series A |
| 1984 Ventures | Seed |
| Insight Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2026
Grew 25% QoQ, from 67 to 84 employees.
- Jun 2, 2026
Nearly doubled headcount in the months leading up to June 2026.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_revenueAug 20, 2026
ExaCare, Inc. reaches an estimated $5.1M in revenue in Dec '25.
For institutional investors. Book with your work email.
ExaCare AI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ExaCare AI's valuation, stock price, and market status.
Is ExaCare AI a public or private company?
ExaCare AI is a private company.
What is the current stock price of ExaCare AI?
ExaCare AI is a private company, so its shares have no public market price. Caplight tracks ExaCare AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ExaCare AI worth (valuation)?
Valuation information for ExaCare AI is not publicly available.
Can I buy ExaCare AI stock?
ExaCare AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ExaCare AI's last funding round?
ExaCare AI's most recent funding round was Series A on October 16, 2025.
Who are the main investors in ExaCare AI?
Key investors in ExaCare AI include Foundation Capital, Insight Partners.
Will ExaCare AI IPO soon?
No public IPO plans have been announced for ExaCare AI.
How can I track ExaCare AI secondary market activity?
Caplight tracks bids, offers, and trades in ExaCare AI's shares on secondary markets.